Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation
Open Access
- 1 September 2016
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (9) , 1646-1653
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein–Barr virus-specific T cells as targets of interest in immunotherapeutic approachesJournal of Immunological Methods, 2014
- Patient, Virus, and Treatment-Related Risk Factors in Pediatric Adenovirus Infection after Stem Cell Transplantation: Results of a Routine Monitoring ProgramTransplantation and Cellular Therapy, 2014
- CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2013
- Pre-emptive virology screening in the pediatric hematopoietic stem cell transplant population: A cost effectiveness analysisHematology/Oncology and Stem Cell Therapy, 2013
- Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation in Pediatric Patients and Subsequent Supportive CareOncology Nursing Forum, 2012
- An International Multicenter Performance Analysis of Cytomegalovirus Load TestsClinical Infectious Diseases, 2012
- Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein–Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplantCytotherapy, 2012
- Multiple viral infections post-hematopoietic stem cell transplantation are linked to the appearance of chronic GVHD among pediatric recipients of allogeneic graftsPediatric Transplantation, 2009
- Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategiesTransplantation and Cellular Therapy, 2003
- High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitutionBlood, 2002